Release Date: 28/06/19 09:50 Summary: Change of Director's Interest Notice - Patrick Walta Price Sensitive: No Download Document 78.39KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%